The enormous success of cancer treatment has resulted in a substantial increase in survival rates. As a result, it has become increasingly necessary to develop opportunities for all survivors to preserve their fertility.
This Campus course will focus specifically on those women and young girls at risk of premature ovarian failure following gonadotoxic treatment (such as chemotherapy), the risk / benefit balance of using different strategic approaches depending on urgency, and the effectiveness of techniques such as transplantation of frozenthawed ovarian tissue.
The course will discuss more recent techniques, such as in vitro maturation for urgent cases, and other approaches which are still at the more experimental phase but which appear promising tools to avoid the re-implantation of malignant ovarian cells.
There will be debates on the ethical issues raised by this revolution of reproduction in oncofertility and surrogacy, and discussion of the preferences and well-being of oncology patients in relation to their fertility.
Medical doctors (gynecologists, oncologists, pediatric oncologists), psychologists, nurses, lab technicians) embryologists, cryobiologists
The subject of this course are those women and female children diagnosed with
cancer who can benefit from fertility preservation. The course will be pragmatic and practical, describing how to develop cryobiological platforms in a multidisciplinary manner and how to use the different strategical approaches depending on the gonadotoxic urgency.
Specifically, the experts will discuss:
This is a multidisciplinary course dealing with social and health sciences in a broad holistic context.
The official language of the course is English.
Participants can only obtain a certificate of attendance after completing the online evaluation. After the course, ESHRE will send an e-mail with the link and more information.